Family · Pharmaceutical analytical standards
Ropinirole
A non-ergoline dopamine agonist first developed for Parkinson's disease: it mimics dopamine in the brain areas that control movement and is also used for restless legs syndrome. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?In 2005 it became the first medicine approved in the United States for restless legs syndrome, a disorder that creates an urge to move the legs, especially in the evening and at night.
No product matches your search.
EDQM standards 6
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
